NuGen Medical Devices Inc.
NGMDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 56.8% | -81.1% | -71.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 60.9% | 60.2% | 55.3% | 54.1% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -2,598.1% | -6,429.5% | 2,051.9% | 332% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -5,383.1% | -10,520.5% | 1,339.5% | 122.7% |
| EPS Diluted | -0.008 | -0.01 | 0.007 | 0.002 |
| % Growth | 21.6% | -247.8% | 200% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |